Treatment of PCa cells with CCL5 promotes phenotypic changes, such as epithelial–mesenchymal transition (EMT), along with STAT3 upregulation, phosphorylation, and nuclear translocation, highlighting the CCL5-STAT3 axis as a driver of tumor aggressiveness. Here, CCL5 is linked to neoplasm.